Carter E Tharpe, MD | |
682 Hemlock St, Suite 490, Macon, GA 31201-6883 | |
(478) 741-1208 | |
(478) 741-1557 |
Full Name | Carter E Tharpe |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 25 Years |
Location | 682 Hemlock St, Macon, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972547651 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 1056929 (Georgia) | Primary |
207RI0011X | Internal Medicine - Interventional Cardiology | 1056929 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medical Center, Navicent Health (the) | Macon, GA | Hospital |
Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
Monroe County Hospital | Forsyth, GA | Hospital |
Houston Medical Center | Warner robins, GA | Hospital |
Taylor Regional Hospital | Hawkinsville, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Georgia Heart Center, Pc | 0446248736 | 25 |
Health Services Of Central Georgia | 9638076730 | 205 |
News Archive
Organic–inorganic hybrid materials, uniting the advantages of their organic and inorganic parts, are used for a wide variety of applications. However, making a homogeneous composite material is only possible if a solvent can be found in which both components are soluble.
New analysis by MoneySuperMarket today reveals that smoking, including e-cigarettes, can increase the cost of life insurance premiums by as much as 65 percent, which equates to over £312 every year.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.
› Verified 9 days ago
Entity Name | Health Services Of Central Georgia |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184679482 PECOS PAC ID: 9638076730 Enrollment ID: O20031217000270 |
News Archive
Organic–inorganic hybrid materials, uniting the advantages of their organic and inorganic parts, are used for a wide variety of applications. However, making a homogeneous composite material is only possible if a solvent can be found in which both components are soluble.
New analysis by MoneySuperMarket today reveals that smoking, including e-cigarettes, can increase the cost of life insurance premiums by as much as 65 percent, which equates to over £312 every year.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.
› Verified 9 days ago
Entity Name | Central Georgia Heart Center, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780779363 PECOS PAC ID: 0446248736 Enrollment ID: O20040505000220 |
News Archive
Organic–inorganic hybrid materials, uniting the advantages of their organic and inorganic parts, are used for a wide variety of applications. However, making a homogeneous composite material is only possible if a solvent can be found in which both components are soluble.
New analysis by MoneySuperMarket today reveals that smoking, including e-cigarettes, can increase the cost of life insurance premiums by as much as 65 percent, which equates to over £312 every year.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Carter E Tharpe, MD 682 Hemlock St, Suite 490, Macon, GA 31201-6883 Ph: (478) 741-1208 | Carter E Tharpe, MD 682 Hemlock St, Suite 490, Macon, GA 31201-6883 Ph: (478) 741-1208 |
News Archive
Organic–inorganic hybrid materials, uniting the advantages of their organic and inorganic parts, are used for a wide variety of applications. However, making a homogeneous composite material is only possible if a solvent can be found in which both components are soluble.
New analysis by MoneySuperMarket today reveals that smoking, including e-cigarettes, can increase the cost of life insurance premiums by as much as 65 percent, which equates to over £312 every year.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.
› Verified 9 days ago
Mrs. Mary E Mckinley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Hospital Dr, Suite 110, Macon, GA 31217 Phone: 478-841-2707 Fax: 478-841-2708 | |
Dr. Swathi Singanamala, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Martin Luther King Jr Blvd, Suite 200, Macon, GA 31201 Phone: 478-745-5455 Fax: 478-803-5232 | |
Dr. Sebastian Alan Montgomery, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Dr Ste 430, Macon, GA 31217 Phone: 478-751-0480 | |
Sagar Jayant Panse, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 890 2nd St, Suite 201, Macon, GA 31201 Phone: 478-745-4322 Fax: 478-750-8789 | |
Dr. Rana K Munna, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 Preston Ct, Macon, GA 31210 Phone: 478-238-0771 Fax: 478-238-6688 | |
Oliver Wendell Horne Iv, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1062 Forsyth St Ste 1b, Macon, GA 31201 Phone: 478-741-1208 | |
Thomas P Meyer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Hospital Dr Bldg D, Suite 200, Macon, GA 31217 Phone: 478-745-5476 Fax: 478-745-3768 |